We are live on ! Find out more
AAMU

Amundi Asset Management US Portfolio holdings

AUM $131B
1-Year Est. Return 73.57%
This Fund
S&P 500
This Quarter Est. Return
+7.44%
1 Year Est. Return
+73.57%
3 Year Est. Return
+113.87%
5 Year Est. Return
+203.49%
10 Year Est. Return
AUM
$76.3B
AUM Growth
+$6.95B
Cap. Flow
+$3.2B
Cap. Flow %
4.2%
Top 10 Hldgs %
17.17%
Holding
1,688
New
122
Increased
747
Reduced
515
Closed
80

Sector Composition

Rank Sector Weight
1 Technology 18.28%
2 Financials 14.68%
3 Healthcare 14.21%
4 Consumer Discretionary 11.56%
5 Industrials 11.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATNX
1451
DELISTED
Athenex, Inc. Common Stock
ATNX
$84K ﹤0.01%
+270
New +$95K
MACK
1452
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$83K ﹤0.01%
19,828
TSG
1453
DELISTED
The Stars Group Inc.
TSG
$82K ﹤0.01%
+3,300
New +$100K
CDZI icon
1454
Cadiz
CDZI
$291M
$81K ﹤0.01%
+7,300
New +$88.8K
ADAP
1455
DELISTED
Adaptimmune Therapeutics
ADAP
$80K ﹤0.01%
5,909
LTRPA
1456
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$80K ﹤0.01%
5,400
+1,400
+35% +$22.2K
MNTV
1457
DELISTED
Momentive Global Inc. Common Stock
MNTV
$80K ﹤0.01%
+5,000
New +$82.3K
HBIO icon
1458
Harvard Bioscience
HBIO
$29.2M
$78K ﹤0.01%
1,490
KPTI icon
1459
Karyopharm Therapeutics
KPTI
$48M
$78K ﹤0.01%
307
TNK icon
1460
Teekay Tankers
TNK
$2.68B
$78K ﹤0.01%
9,888
+3,000
+44% +$24.9K
PRTA icon
1461
Prothena Corp
PRTA
$450M
$76K ﹤0.01%
+5,800
New +$83.8K
ADVM
1462
DELISTED
Adverum Biotechnologies
ADVM
$75K ﹤0.01%
1,240
CRVS icon
1463
Corvus Pharmaceuticals
CRVS
$1.17B
$74K ﹤0.01%
8,600
ATAXZ
1464
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
$74K ﹤0.01%
13,000
RDI icon
1465
Reading International Class A
RDI
$34.3M
$73K ﹤0.01%
4,600
NTBL
1466
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$70K ﹤0.01%
1,231
SPHS
1467
DELISTED
Sophiris Bio, Inc.
SPHS
$66K ﹤0.01%
+23,800
New +$67.7K
CENT icon
1468
Central Garden & Pet Co
CENT
$2.8B
$65K ﹤0.01%
2,250
PDSB icon
1469
PDS Biotechnology
PDSB
$43.4M
$64K ﹤0.01%
3,920
MGIC
1470
DELISTED
Magic Software Enterprises
MGIC
$63K ﹤0.01%
+7,400
New +$64.5K
SVA
1471
DELISTED
Sinovac Biotech, Ltd
SVA
$63K ﹤0.01%
8,300
ADAM
1472
Adamas Trust
ADAM
$883M
$62K ﹤0.01%
2,550
CPS icon
1473
Cooper-Standard Automotive
CPS
$558M
$60K ﹤0.01%
+500
New +$67K
LMRK
1474
DELISTED
Landmark Infrastructure Partners LP Common Units
LMRK
$58K ﹤0.01%
4,200
CYOU
1475
DELISTED
Changyou.com Limited American Depositary Share
CYOU
$58K ﹤0.01%
+4,400
New +$63.2K

Similar funds

Amundi Asset Management US's Q3 2018 Portfolio in Review

As of Q3 2018, Amundi Asset Management US held 1,688 positions worth $76.3B, up 10% from $69.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Amundi Asset Management US deployed $3.2B of net new capital in Q3 2018, opening 122 new positions and adding to 747 existing holdings. Its largest new stake was Evoqua Water Technologies Corp. Common Stock: 1,208,837 shares worth $21.5M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Microsoft, an estimated $204M trimmed.

  • Amundi Asset Management US's largest Q3 2018 buy was Evoqua Water Technologies Corp. Common Stock: 1,208,837 shares worth $21.5M.
  • Amundi Asset Management US added most to Meta Platforms (Facebook) in Q3 2018, an estimated $233M increase.
  • Amundi Asset Management US's biggest Q3 2018 reduction was Microsoft, cutting an estimated $204M.
  • Amundi Asset Management US fully exited MasTec in Q3 2018, selling an estimated $18.8M.
  • Amundi Asset Management US's ten largest holdings make up 17% of its $76.3B portfolio in Q3 2018.
  • Amundi Asset Management US opened 122 new positions and closed 80 in Q3 2018.
  • Amundi Asset Management US's portfolio value rose 10% quarter-over-quarter to $76.3B.

Based on Amundi Asset Management US's 13F filing for Q3 2018, filed 14 Nov 2018.